FX006: Clinical Trials

5 trials of FX006, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated. 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 35Completed 3, Terminated 2

Follow FX006: new trials by email Literature Review of FX006 trials Research Report on FX006

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Use of Extended Release Triamcinolone in the Treatment of Rotator Cuff Disease
FX006 Injection - Rotator Cuff Tears, Rotator Cuff Tendinitis
Phase 3TerminatedNorthwell Health402020-08-272026-11-04
Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis
FX006, Normal saline - Osteoarthritis, Hip
Phase 3TerminatedPacira Pharmaceuticals, Inc702018-12-122024-01-24
Study to Evaluate the Effect of FX006 on Synovial Inflammation in Patients With OA of the Knee
FX006 32 mg - Osteoarthritis, Knee
Phase 3CompletedPacira Pharmaceuticals, Inc1292018-04-242024-01-24
Study to Assess the Safety of Repeat Administration of FX006 Administered to Patients With Osteoarthritis of the Knee
FX006 32 mg - Osteoarthritis of the Knee
Phase 3CompletedPacira Pharmaceuticals, Inc2082017-02-202024-01-24
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
FX006, Placebo, TCA IR 40 - Osteoarthritis of the Knee
Phase 3CompletedPacira Pharmaceuticals, Inc4862015-01-012024-01-24

Conditions studied

Osteoarthritis (4)  ·  Pain (4)  ·  Osteoarthritis, Knee (3)  ·  Osteoarthritis, Hip (1)  ·  Rotator Cuff Injuries (1)  ·  Shoulder Impingement Syndrome (1)

Sponsors

Pacira Pharmaceuticals, Inc (4)  ·  Northwell Health (1)

Countries

United States (5)  ·  Australia (1)  ·  Canada (1)  ·  Denmark (1)  ·  Estonia (1)  ·  Hong Kong (1)  ·  Lithuania (1)  ·  Romania (1)  ·  United Kingdom (1)

Top investigators

Scott Kelley, MD (3)  ·  Neil Bodick, MD (1)  ·  Russell Camhi (1)

Results publications

PMID 29664865, PMID 30741382, PMID 30968336, PMID 34791634